0 XP   0   0   0

Prescient Therapeutics Ltd










Financial Health of Prescient Therapeutics Ltd




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Prescient Therapeutics Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Prescient Therapeutics Ltd?

I guess you are interested in Prescient Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Prescient Therapeutics Ltd

Let's start. I'm going to help you getting a better view of Prescient Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Prescient Therapeutics Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Prescient Therapeutics Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Prescient Therapeutics Ltd. The closing price on 2022-12-08 was A$0.14 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Prescient Therapeutics Ltd Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Prescient Therapeutics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Prescient Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -8,334.9% means that $-83.35 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Prescient Therapeutics Ltd:

  • The MRQ is -8,334.9%. The company is making a huge loss. -2
  • The TTM is -6,698.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-8,334.9%TTM-6,698.9%-1,636.1%
TTM-6,698.9%YOY-3,278.5%-3,420.4%
TTM-6,698.9%5Y-2,678.5%-4,020.4%
5Y-2,678.5%10Y-2,753.7%+75.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,334.9%-223.6%-8,111.3%
TTM-6,698.9%-281.7%-6,417.2%
YOY-3,278.5%-344.8%-2,933.7%
5Y-2,678.5%-450.1%-2,228.4%
10Y-2,753.7%-541.0%-2,212.7%
1.1.2. Return on Assets

Shows how efficient Prescient Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • -14.2% Return on Assets means that Prescient Therapeutics Ltd generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Prescient Therapeutics Ltd:

  • The MRQ is -14.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.2%TTM-10.2%-4.0%
TTM-10.2%YOY-7.8%-2.4%
TTM-10.2%5Y-7.7%-2.4%
5Y-7.7%10Y29.1%-36.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.2%-9.9%-4.3%
TTM-10.2%-8.9%-1.3%
YOY-7.8%-9.3%+1.5%
5Y-7.7%-11.7%+4.0%
10Y29.1%-12.7%+41.8%
1.1.3. Return on Equity

Shows how efficient Prescient Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • -14.9% Return on Equity means Prescient Therapeutics Ltd generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Prescient Therapeutics Ltd:

  • The MRQ is -14.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.9%TTM-10.5%-4.4%
TTM-10.5%YOY-8.1%-2.5%
TTM-10.5%5Y-8.1%-2.4%
5Y-8.1%10Y8.4%-16.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.9%-12.0%-2.9%
TTM-10.5%-11.5%+1.0%
YOY-8.1%-10.8%+2.7%
5Y-8.1%-14.2%+6.1%
10Y8.4%-15.2%+23.6%

1.2. Operating Efficiency of Prescient Therapeutics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Prescient Therapeutics Ltd is operating .

  • Measures how much profit Prescient Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -4,266.6% means the company generated $-42.67  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Prescient Therapeutics Ltd:

  • The MRQ is -4,266.6%. The company is operating very inefficient. -2
  • The TTM is -3,403.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4,266.6%TTM-3,403.6%-863.1%
TTM-3,403.6%YOY-1,674.0%-1,729.5%
TTM-3,403.6%5Y-1,724.9%-1,678.6%
5Y-1,724.9%10Y-883.0%-841.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4,266.6%-207.3%-4,059.3%
TTM-3,403.6%-271.0%-3,132.6%
YOY-1,674.0%-325.9%-1,348.1%
5Y-1,724.9%-454.0%-1,270.9%
10Y-883.0%-537.1%-345.9%
1.2.2. Operating Ratio

Measures how efficient Prescient Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y7.869-7.869
5Y7.86910Y24.117-16.248
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y7.8695.132+2.737
10Y24.1176.371+17.746

1.3. Liquidity of Prescient Therapeutics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Prescient Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 17.61 means the company has $17.61 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 17.609. The company is very able to pay all its short-term debts. +2
  • The TTM is 28.913. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ17.609TTM28.913-11.304
TTM28.913YOY57.146-28.233
TTM28.9135Y26.535+2.378
5Y26.53510Y17.248+9.287
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.6095.117+12.492
TTM28.9135.755+23.158
YOY57.1465.854+51.292
5Y26.5356.511+20.024
10Y17.2486.222+11.026
1.3.2. Quick Ratio

Measures if Prescient Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 15.30 means the company can pay off $15.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 15.303. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.830. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ15.303TTM14.830+0.473
TTM14.830YOY29.054-14.224
TTM14.8305Y13.990+0.840
5Y13.99010Y9.449+4.541
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.3034.284+11.019
TTM14.8304.664+10.166
YOY29.0544.787+24.267
5Y13.9905.218+8.772
10Y9.4495.182+4.267

1.4. Solvency of Prescient Therapeutics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Prescient Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Prescient Therapeutics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that Prescient Therapeutics Ltd assets are financed with 4.9% credit (debt) and the remaining percentage (100% - 4.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 0.049. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.030. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.049TTM0.030+0.019
TTM0.030YOY0.031-0.001
TTM0.0305Y0.042-0.012
5Y0.04210Y3.034-2.992
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0490.278-0.229
TTM0.0300.277-0.247
YOY0.0310.306-0.275
5Y0.0420.367-0.325
10Y3.0340.403+2.631
1.4.2. Debt to Equity Ratio

Measures if Prescient Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.1% means that company has $0.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Prescient Therapeutics Ltd:

  • The MRQ is 0.051. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.031. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.051TTM0.031+0.020
TTM0.031YOY0.032-0.001
TTM0.0315Y0.044-0.013
5Y0.04410Y1.295-1.251
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0510.315-0.264
TTM0.0310.317-0.286
YOY0.0320.319-0.287
5Y0.0440.403-0.359
10Y1.2950.462+0.833

2. Market Valuation of Prescient Therapeutics Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Prescient Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare Prescient Therapeutics Ltd to the Biotechnology industry mean.
  • A PE ratio of -89.18 means the investor is paying $-89.18 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Prescient Therapeutics Ltd:

  • The EOD is -80.552. Company is losing money. -2
  • The MRQ is -89.183. Company is losing money. -2
  • The TTM is -110.549. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-80.552MRQ-89.183+8.631
MRQ-89.183TTM-110.549+21.367
TTM-110.549YOY-81.351-29.199
TTM-110.5495Y-67.802-42.747
5Y-67.80210Y107.440-175.242
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-80.552-8.986-71.566
MRQ-89.183-9.792-79.391
TTM-110.549-16.243-94.306
YOY-81.351-20.876-60.475
5Y-67.802-16.665-51.137
10Y107.440-14.732+122.172

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Prescient Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.65 means the investor is paying $6.65 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Prescient Therapeutics Ltd:

  • The EOD is 6.010. Seems overpriced? -1
  • The MRQ is 6.654. Seems overpriced? -1
  • The TTM is 7.575. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD6.010MRQ6.654-0.644
MRQ6.654TTM7.575-0.921
TTM7.575YOY4.675+2.900
TTM7.5755Y5.127+2.448
5Y5.12710Y-40.936+46.063
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.0101.835+4.175
MRQ6.6542.006+4.648
TTM7.5752.774+4.801
YOY4.6753.453+1.222
5Y5.1272.713+2.414
10Y-40.9362.402-43.338
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Prescient Therapeutics Ltd.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Prescient Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.001-51%0.003-181%0.000-849%0.001-502%
Book Value Growth--0.2530.293-14%0.396-36%0.326-22%0.318-20%
Book Value Per Share--0.0230.026-10%0.027-12%0.020+18%0.014+69%
Book Value Per Share Growth---0.111-0.052-53%0.101-210%-0.002-98%0.082-235%
Current Ratio--17.60928.913-39%57.146-69%26.535-34%17.248+2%
Debt To Asset Ratio--0.0490.030+63%0.031+59%0.042+16%3.034-98%
Debt To Equity Ratio--0.0510.031+65%0.032+58%0.044+16%1.295-96%
Dividend Per Share----0%-0%-0%-0%
Eps---0.002-0.002+2%-0.001-17%-0.002-11%-0.001-44%
Eps Growth----0.0140%-0.0830%0.073-100%0.012-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---83.349-66.989-20%-32.785-61%-26.785-68%-27.537-67%
Operating Margin---42.666-34.036-20%-16.740-61%-17.249-60%-8.830-79%
Operating Ratio----0%-0%7.869-100%24.117-100%
Pb Ratio6.010-11%6.6547.575-12%4.675+42%5.127+30%-40.936+715%
Pe Ratio-80.552+10%-89.183-110.549+24%-81.351-9%-67.802-24%107.440-183%
Price Per Share0.140-11%0.1550.198-22%0.123+27%0.102+52%0.309-50%
Price To Total Gains Ratio-54.070+10%-59.864-75.863+27%-43.389-28%-5439535.335+9086437%-2801193.046+4679186%
Profit Growth---66.380-17.821-73%-41.301-38%-32.178-52%-27.330-59%
Quick Ratio--15.30314.830+3%29.054-47%13.990+9%9.449+62%
Return On Assets---0.142-0.102-28%-0.078-45%-0.077-45%0.291-149%
Return On Equity---0.149-0.105-29%-0.081-46%-0.081-46%0.084-279%
Revenue Growth--1.0001.0000%1.0000%-0.889+189%-3.545+454%
Total Gains Per Share---0.003-0.001-51%0.003-181%0.000-849%0.001-502%
Total Gains Per Share Growth---1.000-1.0000%--100%174077.943-100%89335.783-100%
Usd Book Value--11271045.82912513508.398-10%12832872.679-12%9580682.020+18%6683866.192+69%
Usd Book Value Change Per Share---0.002-0.001-51%0.002-181%0.000-849%0.000-502%
Usd Book Value Per Share--0.0160.017-10%0.018-12%0.013+18%0.009+69%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.001+2%-0.001-17%-0.001-11%-0.001-44%
Usd Price Per Share0.094-11%0.1040.133-22%0.082+27%0.069+52%0.208-50%
Usd Profit---1681880.844-1290294.920-23%-1034545.773-38%-784527.062-53%-490933.907-71%
Usd Revenue--20178.7247426.658+172%11141.668+81%68381.668-70%65111.619-69%
Usd Total Gains Per Share---0.002-0.001-51%0.002-181%0.000-849%0.000-502%
 EOD+3 -2MRQTTM+7 -20YOY+3 -255Y+9 -2210Y+12 -19

4.2. Fundamental Score

Let's check the fundamental score of Prescient Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-80.552
Price to Book Ratio (EOD)Between0-16.010
Net Profit Margin (MRQ)Greater than0-83.349
Operating Margin (MRQ)Greater than0-42.666
Quick Ratio (MRQ)Greater than115.303
Current Ratio (MRQ)Greater than117.609
Debt to Asset Ratio (MRQ)Less than10.049
Debt to Equity Ratio (MRQ)Less than10.051
Return on Equity (MRQ)Greater than0.15-0.149
Return on Assets (MRQ)Greater than0.05-0.142
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Prescient Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.150
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets17,618
Total Liabilities856
Total Stockholder Equity16,762
 As reported
Total Liabilities 856
Total Stockholder Equity+ 16,762
Total Assets = 17,618

Assets

Total Assets17,618
Total Current Assets14,247
Long-term Assets14,247
Total Current Assets
Cash And Cash Equivalents 12,264
Short-term Investments 20
Net Receivables 78
Other Current Assets 1,885
Total Current Assets  (as reported)14,247
Total Current Assets  (calculated)14,247
+/-0
Long-term Assets
Property Plant Equipment 5
Intangible Assets 3,367
Long-term Assets  (as reported)3,372
Long-term Assets  (calculated)3,372
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities809
Long-term Liabilities47
Total Stockholder Equity16,762
Total Current Liabilities
Accounts payable 505
Other Current Liabilities 304
Total Current Liabilities  (as reported)809
Total Current Liabilities  (calculated)809
+/-0
Long-term Liabilities
Other Liabilities 47
Long-term Liabilities  (as reported)47
Long-term Liabilities  (calculated)47
+/-0
Total Stockholder Equity
Common Stock77,264
Retained Earnings -62,452
Other Stockholders Equity 1,950
Total Stockholder Equity (as reported)16,762
Total Stockholder Equity (calculated)16,762
+/-0
Other
Capital Stock77,264
Cash and Short Term Investments 12,284
Common Stock Shares Outstanding 654,323
Liabilities and Stockholders Equity 17,618
Net Debt -12,264
Net Invested Capital 16,762
Net Tangible Assets 13,396
Net Working Capital 13,438



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-31
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
162
0
0
0
0
0
0
0
2,798
0
0
1,384
1,384
5,143
5,143
4,282
4,282
2,608
2,608
1,904
1,904
1,774
1,774
1,634
1,634
2,379
2,379
4,148
4,148
4,342
4,342
4,183
4,183
2,548
2,548
3,708
3,708
2,214
2,214
3,244
3,244
1,200
1,200
1,751
1,750
808
808
1,182
1,182
720
720
1,568
1,568
1,350
1,350
702
702
260
260
62
62
0
0
0
0
1,626
1,626
5,280
5,280
5,646
5,646
4,892
4,892
6,203
6,203
13,835
13,835
13,469
13,469
12,230
12,230
10,947
10,947
9,991
9,991
8,489
8,489
15,007
15,007
13,394
13,394
0
12,072
0
22,625
0
20,967
0
19,057
0
17,618
17,618019,057020,967022,625012,072013,39413,39415,00715,0078,4898,4899,9919,99110,94710,94712,23012,23013,46913,46913,83513,8356,2036,2034,8924,8925,6465,6465,2805,2801,6261,626000062622602607027021,3501,3501,5681,5687207201,1821,1828088081,7501,7511,2001,2003,2443,2442,2142,2143,7083,7082,5482,5484,1834,1834,3424,3424,1484,1482,3792,3791,6341,6341,7741,7741,9041,9042,6082,6084,2824,2825,1435,1431,3841,384002,79800000001620000000000000000000000000000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150
0
0
0
0
0
0
0
2,787
0
0
0
1,370
0
0
0
4,255
0
0
0
1,875
0
0
0
1,592
0
0
0
3,873
0
0
0
4,183
0
0
0
3,686
0
0
0
3,230
0
0
0
1,745
0
0
0
1,180
0
0
0
1,563
0
0
0
698
0
0
0
62
0
0
0
0
0
0
0
3,935
0
0
0
1,525
0
0
0
10,467
10,102
10,102
8,861
8,861
7,577
7,577
6,622
6,622
5,121
5,121
11,639
11,639
10,026
10,026
8,705
8,705
19,257
19,257
17,598
17,598
15,688
15,688
14,247
14,247
14,24714,24715,68815,68817,59817,59819,25719,2578,7058,70510,02610,02611,63911,6395,1215,1216,6226,6227,5777,5778,8618,86110,10210,10210,4670001,5250003,9350000000620006980001,5630001,1800001,7450003,2300003,6860004,1830003,8730001,5920001,8750004,2550001,3700002,78700000001500000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150
0
0
0
0
0
0
0
2,716
0
0
0
1,355
0
0
0
3,735
0
0
0
1,821
0
0
0
1,536
0
0
0
3,812
0
0
0
4,111
0
0
0
3,553
0
0
0
1,574
0
0
0
1,631
0
0
0
1,071
0
0
0
1,384
0
0
0
584
0
0
0
29
0
0
0
0
0
0
0
3,809
0
0
0
1,043
0
0
0
9,754
5,929
5,929
7,645
7,645
5,987
5,987
5,486
5,486
3,310
3,310
9,640
9,640
5,716
5,716
0
7,357
0
18,448
0
16,098
0
14,766
0
12,264
12,264014,766016,098018,44807,35705,7165,7169,6409,6403,3103,3105,4865,4865,9875,9877,6457,6455,9295,9299,7540001,0430003,8090000000290005840001,3840001,0710001,6310001,5740003,5530004,1110003,8120001,5360001,8210003,7350001,3550002,71600000001500000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,520
3,520
20
20
20
20
20
20
20
20
20
20
3,520
3,520
0
20
0
20
0
20
0
20
0
20
2002002002002003,5203,520202020202020202020203,5203,520000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71
0
0
14
15
170
170
510
273
363
363
49
49
84
84
18
17
26
26
57
56
96
96
26
26
52
52
77
72
598
598
1,577
1,577
113
113
61
61
94
94
58
58
77
77
134
134
598
598
44
44
29
29
15
15
0
0
0
0
115
115
127
127
194
194
428
216
863
863
664
20
569
569
1,080
22
1,464
17
985
46
1,651
17
1,748
117
660
660
1,060
30
655
655
1,239
54
768
768
1,718
78
781,718768768541,239655655301,0606606601171,748171,65146985171,464221,08056956920664863863216428194194127127115115000015152929444459859813413477775858949461611131131,5771,57759859872775252262696965657262617188484494936336327351017017015140071000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
10
246
5
5
5
5
5
5
38
38
27
27
5
5
107
107
46
46
214
214
57
62
178
178
79
79
121
121
53
53
118
118
51
51
101
101
45
45
99
99
70
69
25
25
18
18
0
0
0
0
0
0
0
0
55
55
54
265
43
43
49
694
83
83
116
1,174
105
1,552
39
1,070
0
0
1,631
1,862
599
599
0
1,298
0
0
1,185
1,427
702
702
0
1,885
1,88507027021,4271,185001,29805995991,8621,631001,070391,5521051,17411683836944943432655455550000000018182525697099994545101101515111811853531211217979178178625721421446461071075527273838555555246101111000000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
0
0
0
0
0
0
10
0
0
0
14
0
0
0
27
0
0
0
29
0
0
0
42
0
0
0
275
0
0
0
0
0
0
0
21
0
0
0
15
0
0
0
6
0
0
0
2
0
0
0
5
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
1,344
0
0
0
3,367
0
0
0
3,368
0
0
0
3,369
0
0
0
3,369
0
0
0
3,368
0
0
0
3,367
0
0
0
3,369
0
0
0
3,372
3,3720003,3690003,3670003,3680003,3690003,3690003,3680003,3670001,3440000000000040005000200060001500021000000027500042000290002700014000100000000120000000000000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
0
0
0
0
0
0
10
0
0
14
14
24
24
27
27
31
31
29
29
33
33
42
42
35
35
275
275
250
250
0
0
9
9
21
21
22
22
15
15
8
8
6
6
5
5
2
2
2
2
5
5
5
5
4
4
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
2
2
3
3
2
2
2
2
1
1
0
0
0
0
2
2
2
2
1
1
5
5
55112222000011222233221111000000000000000033445555222255668815152222212199002502502752753535424233332929313127272424141400100000000120000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,344
1,344
3,067
3,067
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
0
3,367
0
3,367
0
3,367
0
3,367
0
3,367
3,36703,36703,36703,36703,36703,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,0673,0671,3441,34400000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,344
1,344
3,067
3,067
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
3,367
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,0673,0671,3441,34400000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137
0
0
0
0
0
0
0
120
0
0
108
108
627
627
668
668
436
436
448
448
536
536
680
680
525
525
511
511
2,649
2,649
1,353
1,353
1,639
1,639
1,681
1,681
1,642
1,642
1,476
1,476
785
785
1,677
1,677
1,532
1,532
1,786
1,786
1,237
1,237
1,289
1,289
1,202
1,202
1,534
1,534
1,409
1,409
1,849
1,849
0
0
0
0
35
35
253
253
438
438
441
441
618
618
823
823
232
232
445
445
280
280
552
552
512
512
686
686
663
663
0
884
0
263
0
540
0
431
0
856
85604310540026308840663663686686512512552552280280445445232232823823618618441441438438253253353500001,8491,8491,4091,4091,5341,5341,2021,2021,2891,2891,2371,2371,7861,7861,5321,5321,6771,6777857851,4761,4761,6421,6421,6811,6811,6391,6391,3531,3532,6492,6495115115255256806805365364484484364366686686276271081080012000000001370000000000000000000000000000000000
   > Total Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137
0
0
0
0
0
0
0
120
0
0
108
108
627
627
668
668
436
436
448
448
536
536
680
680
525
525
511
511
2,649
2,649
1,315
1,353
1,639
1,639
1,660
1,660
1,622
1,622
1,469
1,468
771
771
373
373
1,532
1,532
1,786
1,786
397
397
392
392
1,202
1,202
1,534
1,534
1,409
1,409
1,849
1,849
0
0
0
0
35
35
253
253
438
438
439
439
618
618
822
822
232
232
441
441
274
273
544
544
501
501
668
668
641
641
864
864
240
240
515
515
390
390
809
809
809809390390515515240240864864641641668668501501544544273274441441232232822822618618439439438438253253353500001,8491,8491,4091,4091,5341,5341,2021,2023923923973971,7861,7861,5321,5323733737717711,4681,4691,6221,6221,6601,6601,6391,6391,3531,3152,6492,6495115115255256806805365364484484364366686686276271081080012000000001370000000000000000000000000000000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,508
0
0
0
0
0
0
0
1,035
0
0
0
1,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
56
56
0
0
0
20
0
0
0
157
0
0
0
166
0
0
0
0
0000166000157000200005656002000000000000000000001,1000001,03500000001,5080000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56
56
0
0
0
0
0
0
0
157
0
0
0
166
0
0
0
0
000016600015700000005656000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104
104
627
627
139
139
0
0
365
365
0
0
0
0
328
328
0
0
259
259
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
337
337
0
0
165
165
0
0
204
204
0
0
0
0
0
0
35
35
217
217
425
425
397
397
605
605
309
309
209
209
341
341
213
213
243
243
403
403
393
393
528
528
480
480
180
180
233
233
293
293
505
505
5055052932932332331801804804805285283933934034032432432132133413412092093093096056053973974254252172173535000000204204001651650033733700000000000000000025925900328328000036536500139139627627104104000000000000000000000000000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137
0
0
0
0
0
0
0
120
0
0
4
4
0
0
528
528
436
436
84
84
536
536
680
680
197
197
511
251
2,389
2,389
1,314
988
1,639
1,639
1,660
669
1,622
1,622
1,469
1,468
771
771
373
373
88
88
278
278
60
60
391
392
71
71
498
329
100
100
749
749
0
0
0
0
0
0
35
253
13
13
42
439
13
13
514
514
23
23
100
100
61
61
37
244
0
0
42
275
0
0
182
227
0
0
45
116
0
0
184
304
30418400116450022718200275420024437616110010023235145141313439421313253350000007497491001003294987171392391606027827888883733737717711,4681,4691,6221,6226691,6601,6391,6399881,3142,3892,389251511197197680680536536848443643652852800440012000000001370000000000000000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
0
0
0
8
0
0
0
1,305
0
0
0
0
0
0
0
897
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
4
0
0
0
8
0
0
0
18
0
0
0
20
0
0
0
25
0
0
0
47
470002500020000180008000400000002000000000000000000089700000001,3050008000210000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38
0
0
0
21
21
20
20
8
8
14
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
0
0
0
0
1
1
4
4
6
6
8
8
11
11
18
18
22
22
20
20
22
22
25
25
41
41
47
47
47474141252522222020222218181111886644110000330000000000000000000000000000141488202021210003800000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24
0
0
0
0
0
0
0
2,678
0
0
1,277
1,277
4,515
4,515
3,615
3,614
2,172
2,172
1,456
1,456
1,238
1,238
954
954
1,854
1,854
3,637
3,637
1,694
1,694
2,830
2,830
909
909
2,027
2,027
572
572
1,768
1,768
414
414
73
73
0
0
0
-604
0
0
279
279
148
148
0
-832
0
0
0
-1,787
0
0
0
0
1,591
1,591
5,027
5,027
5,208
5,208
4,451
4,450
5,585
5,585
13,013
13,013
13,237
13,237
11,785
11,785
10,667
10,667
9,439
9,439
7,977
7,977
14,321
14,321
12,731
12,731
0
11,188
0
22,363
0
20,427
0
18,626
0
16,762
16,762018,626020,427022,363011,188012,73112,73114,32114,3217,9777,9779,4399,43910,66710,66711,78511,78513,23713,23713,01313,0135,5855,5854,4504,4515,2085,2085,0275,0271,5911,5910000-1,787000-832014814827927900-60400073734144141,7681,7685725722,0272,0279099092,8302,8301,6941,6943,6373,6371,8541,8549549541,2381,2381,4561,4562,1722,1723,6143,6154,5154,5151,2771,277002,6780000000240000000000000000000000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,707
0
0
0
0
0
0
0
7,472
0
0
8,353
8,353
12,980
12,980
12,984
12,984
12,984
12,984
13,473
13,473
15,149
15,149
16,106
16,106
19,361
19,361
22,753
22,753
22,756
22,756
25,945
25,945
26,195
26,195
29,667
29,667
30,378
30,378
31,973
31,973
31,973
31,973
31,973
31,973
31,973
31,973
32,642
32,642
33,334
33,334
35,104
35,104
35,225
35,225
35,298
35,298
36,077
36,077
36,216
36,216
36,216
36,216
36,216
36,216
38,521
38,521
42,497
42,497
43,693
43,693
43,994
43,994
45,771
45,771
54,277
54,277
55,497
55,497
55,497
55,497
55,497
55,497
55,571
55,571
55,574
55,574
63,930
63,930
63,930
63,930
63,930
63,930
76,640
76,640
76,671
76,671
76,997
76,997
77,264
77,264
77,26477,26476,99776,99776,67176,67176,64076,64063,93063,93063,93063,93063,93063,93055,57455,57455,57155,57155,49755,49755,49755,49755,49755,49754,27754,27745,77145,77143,99443,99443,69343,69342,49742,49738,52138,52136,21636,21636,21636,21636,21636,21636,07736,07735,29835,29835,22535,22535,10435,10433,33433,33432,64232,64231,97331,97331,97331,97331,97331,97331,97331,97330,37830,37829,66729,66726,19526,19525,94525,94522,75622,75622,75322,75319,36119,36116,10616,10615,14915,14913,47313,47312,98412,98412,98412,98412,98012,9808,3538,353007,47200000001,7070000000000000000000000000000000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-12
0
0
0
-15
0
0
0
-8
0
0
0
-34
0
0
0
-51
0
0
0
-109
0
0
0
-467
0
0
0
186
0
0
0
288
0
0
0
288
0
0
0
288
0
0
0
478
0
0
0
534
0
0
0
553
0
0
0
0
0
0
0
43
0
0
0
576
0
0
0
609
0
0
0
729
0
0
0
883
0
0
0
1,100
0
0
0
716
0
0
0
1,264
0
0
0
1,950
1,9500001,2640007160001,100000883000729000609000576000430000000553000534000478000288000288000288000186000-467000-109000-51000-34000-8000-15000-12000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
655
0
0
0
0
0
0
0
12
0
0
0
15
0
0
0
8
0
0
0
34
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
637
637
729
729
791
791
883
883
925
166
1,100
206
1,187
1,187
716
716
969
969
1,264
1,264
1,748
1,748
1,950
1,950
1,9501,9501,7481,7481,2641,2649699697167161,1871,1872061,10016692588388379179172972963763700000000000000000000000000000000000000000000000000000000340008000150001200000006550000000000000000000000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.